Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2005
08/17/2005EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/17/2005EP1122253B1 Quinazolinone derivatives
08/17/2005EP0991638B1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS
08/17/2005EP0989982B1 Barbituric acid derivatives with antimetastatic and antitumor activity
08/17/2005EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
08/17/2005CN1656109A Non nucleoside reverse transcriptase inhibitors
08/17/2005CN1656090A Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
08/17/2005CN1656082A Protein kinase inhibitors
08/17/2005CN1656081A 4-anilino quinazoline derivatives as antiproliferative agents
08/17/2005CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound
08/17/2005CN1656078A Aminoindazole derivatives as protein kinase inhibitor
08/17/2005CN1656075A Quinoline derivatives and their use as 5-HT6 ligands
08/17/2005CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
08/17/2005CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
08/17/2005CN1656071A New piperidine derivative
08/17/2005CN1656070A Melanocortin receptor ligands
08/17/2005CN1656066A Pharmaceutical combination
08/17/2005CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
08/17/2005CN1655779A Substituted benzazoles and methods of their use as inhibitors of Raf kinase
08/17/2005CN1654459A Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof
08/17/2005CN1215067C 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors
08/17/2005CN1215066C Novel indole derivatives and their use as medicaments
08/17/2005CN1215061C Process for preparing anticancer compound, and intermediate
08/17/2005CN1215059C Novel heterocyclic compounds and salts thereof and medicinal use of same
08/17/2005CN1214792C Highly absorbable solid preparation
08/16/2005US6930185 Anorectic agents; obesity; such as 4'-chloro-N-(6-((N,N-dimethylamino)methyl)-2-naphthyl)(1,1'-biphenyl)-4 -carbox-amide
08/16/2005US6930117 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
08/16/2005US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis
08/16/2005US6930110 Nitrogen compounds such as 5-chloro-4-{4-[4-(2,3-dihydrobenzo[1,4]dioxine-5-yl)-piperazine-1-yl]-butylamino}-2H-piridazin-3-one, used as anxiolytic and hypotensive agents; side effect reduction
08/16/2005US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders
08/16/2005US6930104 beta -amyloid precursor protein secretory stimulators; treating neurodegenerative disorders; n-carbamoyl- quinoxaline or quinoline derivatives
08/16/2005US6930102 16-halogen-epothilone derivatives, process for their production, and their pharmaceutical use
08/16/2005US6929811 Active agent is selected from the group consisting of anabasine, anatabine, nomicotine, Yerbamate (Ilex paraguariensis) extract, and a liquid extract of tobacco; especially for treating psychological disorders
08/16/2005US6929361 excellent in water-solubility, stable in storing the solution and characterized by having a good ability to filter through a membrane filter
08/16/2005CA2342974C Methods and compositions for inhibition of angiogenesis
08/16/2005CA2323707C New substances derived from benzothiophenes, benzofurans and indolics, processes for preparing them and pharmaceutical compounds containing them
08/16/2005CA2323703C New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them
08/16/2005CA2220438C (n-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents
08/16/2005CA2166059C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/11/2005WO2005073230A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
08/11/2005WO2005073229A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
08/11/2005WO2005073224A2 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
08/11/2005WO2005073222A1 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-ht4 receptor agonistic activity
08/11/2005WO2005073218A1 Therapeutic agent for vasospasm accompanying bypass operation
08/11/2005WO2005073217A1 Fused heteroaryl derivatives and their use as p38 kinase inhibitors
08/11/2005WO2005073216A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073195A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073193A1 Vanilloid receptor ligands and their use in treatments
08/11/2005WO2005073192A1 Novel piperidines as chemokine modulators (ccr)
08/11/2005WO2005073189A1 Fused heteroyral derivatives for use as p38 kinase inhibitors
08/11/2005WO2005072733A1 Dyarylurea compounds as chk-1 inhibitors
08/11/2005WO2005072732A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/11/2005WO2005072729A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/11/2005WO2005072681A2 Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain.
08/11/2005WO2005072308A2 Cgrp receptor antagonists
08/11/2005WO2005053663A3 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure
08/11/2005WO2005051914A8 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005WO2005044807A3 Benzoimidazole compounds
08/11/2005WO2005032472A3 Pyrrolidine and piperidine derivatives as factor xa inhibitors
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2004091480A3 Tie-2 modulators and methods of use
08/11/2005US20050176964 Nicotinamide derivatives useful as p38 inhibitors
08/11/2005US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors
08/11/2005US20050176780 2,5-disubstituted 3-mercaptopentanoic acid
08/11/2005US20050176777 administering anabasine, anatabine, nornicotine and carriers, diluents or vehicles, for treatment drug abuse and dependence
08/11/2005US20050176775 Substituted pyridinones
08/11/2005US20050176772 Melanocortin MCR4 agonists; treating female sexual dysfunction, male erectile dysfunction, obesity or diabetes; e.g. [1-tert-Butyl-4-(2,4-difluoro-phenyl)-pyrrolidin-3-yl]-(4-hydroxy-3,5-dimethyl-4-phenyl-piperidin-1-yl)-methanone or its hydrochloride
08/11/2005US20050176771 4-fluoro-1-({[1-(methanesulfonyl)piperidin-4-yl]amino}acetyl)pyrrolidine-2-carbonitrile; insulin-dependent diabetes (type 1 diabetes), non insulin-dependent diabetes (type 2 diabetes), insulin-resistant disorders, obesity; dipeptidyl peptidase IV-inhibiting activity
08/11/2005US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
08/11/2005US20050176767 Pyridine carboxamide and methods for inhibiting HIV integrase
08/11/2005US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one
08/11/2005US20050176764 Medicine for treating cancer
08/11/2005US20050176763 Administering a therapeutically effective amount of 3-thia-4-(2-oxy/hydroxyphenyl)quinolin-2-one derivative to a patient to treat erectile dysfunction or irritable bowel syndrome
08/11/2005US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders
08/11/2005US20050176760 and tumors; imino-, thiocarbonyl- or hydroxyimino-substituted N-heterocyclic amide compounds such as 2-(3-aminomethylphenylamino)-N-[3-chloro-4-(2-hydroxyiminopyrrolidin-1-yl)phenyl]-2-phenylacetamide
08/11/2005US20050176759 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disorders
08/11/2005US20050176744 nitrogen heterocyclyl-(thio)carbonyl- quinoline derivatives used for treating cervical carcinoma or ovarian adenocarcinoma
08/11/2005US20050176740 Synergistic for cancer characterized by ras oncogene overexpression; N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine
08/11/2005US20050176733 Chk-1 inhibitors
08/11/2005US20050176730 Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT 1B/1D ligands
08/11/2005US20050176729 Indole derivatives useful for the treatment of CNS disorders
08/11/2005US20050176727 Male erectile dysfunction; 1-(3-chlorophenyl)-3-(4-pyridin-2-yl-piperazin-1-yl)propan-1-one O-methyloxime
08/11/2005US20050176726 Pyrimidine ether derivatives; antiinflammatory; analgesic; antiarthritis; antirheumatic;diseases involving sensory nerve function; 2-((6-(4-((1S)-1-(4-fluorophenyl)ethyl)-1-piperazinyl)-4-pyrimidinyl)oxy)quinoline
08/11/2005US20050176724 2-Methyl-5-(2-{4-[3-(1-methylpiperidin-4-yl)benzyl]piperidin-1-yl}ethoxy)quinoline hydrochloride; antagonist of 5-serotonin (HT)1 type receptors;antidepressant and anxiolytic agent
08/11/2005US20050176722 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
08/11/2005US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines
08/11/2005US20050176719 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis
08/11/2005US20050176714 Pyridazine derivatives
08/11/2005US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
08/11/2005US20050176712 Integrin expression inhibitor
08/11/2005US20050176711 Phthalazine derivatives for treating inflammatory diseases
08/11/2005US20050176709 Selective NPY (Y5) antagonists
08/11/2005US20050176705 5-Chloro-1-(3,5-dichloro-2-methoxy benzenesulfonyl)-4-piperazin-1-yl-1H-indole trifluoroacetic acid salt; 5-hydroxytryptamine (serotonin) HT6 receptor antagonists; antidepressant, anxiolytic agent, cognition activator; ADHD, Alzheimer's and Parkinson's disease, drug and nicotine abuse
08/11/2005US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof
08/11/2005US20050176698 Neuropeptide Y antagonists
08/11/2005US20050176687 Use of tyrosine kinase inhibitors for treating autoimmune diseases
08/11/2005US20050172420 Based on diaminobenzanilides or, more specifically (aminobenzoylamino),(sulfo-),(methoxy)anilines; stable aqueous solutions;nonbleeding/colorfastness; excellent degrees of exhaustion with high colour strength; dyeing natural or synthetic materials, particularly, paper; neutral or greenish-yellow hues
08/11/2005DE102004003811A1 Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Cyclohexylimidazolinone, processes for their preparation and their use as medicaments
08/11/2005DE102004003493A1 5-Phenylpyrimidine 5-phenylpyrimidines
1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 1080